• 1
    Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002 CA Cancer J Clin. 2002; 52: 2347.
  • 2
    Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986; 150: 195203.
  • 3
    Taylor I, Machin D, Mullee M, Trotter G, Cooke T, West C. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg. 1985; 72: 359363.
  • 4
    Wereldsma JCJ, Bruggink EDM, Meijer WS, Roukema JA, van Putten WLJ. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Cancer. 1990; 65: 425432.
  • 5
    Wolmark N, Rockette H, Wickerham DL, et al. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project protocol C-02. J Clin Oncol. 1990; 8: 14661475.
  • 6
    Beart RW, Moertel CG, Wieand HS, et al. Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion: a study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg. 1990; 125: 897901.
  • 7
    Meta-Analysis Group In Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 1996; 88: 252258.
  • 8
    Kemeny MM, Adak SA, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy – an intergroup study. J Clin Oncol. 2002; 20: 14991505.
  • 9
    Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999; 341: 20392048.
  • 10
    Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma. 1st edition. Tokyo, Kanehara, 1997.
  • 11
    Sadahiro S, Suzuki T, Tokunaga N, Tajima T, Makuuchi H, Ohtaki M. Prevention of hepatic artery occlusion during continuous infusion of fluorouracil using liposteroid. AJR Am J Roentgenol. 2000; 175: 16411642.
  • 12
    Araki T. Manual of abdominal angiography [in Japanese]. 2nd edition. Tokyo: Nankodo, 1998.
  • 13
    Kaplan EL, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 14
    Finlay IG, Meek D, Brunton F, McArdle CS. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg. 1988; 75: 641644.
  • 15
    Thomas WM, Morris DL, Hardcastle JD. Contact ultrasonography in the detection of liver metastases from colorectal cancer: an in vitro study. Br J Surg. 1987; 74: 955956.
  • 16
    Liver Infusion Meta-Analysis Group. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst. 1997; 89: 497505.
  • 17
    Sigurdson ER, Ridge JA, Kemeny N, Daly JM. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol. 1987; 5: 18361840.
  • 18
    Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery. 1974; 75: 589596.
  • 19
    Conway JG, Popp JA, Ji S, Thurman RG. Effect of size on portal circulation of hepatic nodules from carcinogen-treated rats. Cancer Res. 1983; 43: 33743379.
  • 20
    Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg. 1989; 76: 545548.
  • 21
    Ensminger WD, Rosowsky A, Raso V, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res. 1978; 38: 37843792.
  • 22
    Warren HW, Anderson JH, O'Gorman P, et al. A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases. Br J Cancer. 1994; 70: 677680.
  • 23
    Meta-Analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol. 1998; 16: 301308.
  • 24
    Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y. Adjuvant therapy with oral fluoropyrimidines as main chemotherapy agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials. Jpn J Clin Oncol. 1999; 29: 7886.
  • 25
    Sadahiro S, Ohki S, Yamaguchi S, et al. Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. Cancer Chemother Pharmacol. 2000; 46: 180184.